Clinical Trial Update: Clinical Trial to Evaluate Short-term Efficacy of Palliative Methylphenidate in Asthenia in Advanced Cancer Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial to evaluate the short-term efficacy of methylphenidate for asthenia in patients with advanced cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthenia
• Cancer

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Asthenia | Phase 3 | Status: TERMINATED